Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

This week we raise awareness of Parkinson's Disease and related disorders with a unique video insight into the work of the Wade-Martins Group.

This week DPAG is marking World Parkinson's Day, which takes place on Thursday 11 April 2019, with an inside look into the Wade-Martins Laboratory.

The Wade-Martins Group conducts critical research into several neurodegenerative diseases, including Parkinson's Disease, Alzheimer's Disease and Friedreich's Ataxia, with the aim to understand the molecular mechanisms of these disorders and help develop new treatments.

This video is narrated by Professor Richard Wade-Martins, with contributions from Charmaine Lang, Dayne Beccano-Kelly, Peter Kilfeather, Phillippa Carling, Gabriela Vilema Enriquez and former members of the team, Gabriele Corda, Rebecca Wallings and Marta Cherubini.

Similar stories

Fellowship awarded to Mootaz Salman could pave the way for early intervention in Parkinson’s

Congratulations are in order for Departmental Research Lecturer Dr Mootaz Salman who has been awarded a prestigious Early Career Fellowship funded by the Leverhulme Trust.

Researchers discover novel form of adaptation in the auditory system

DPAG’s auditory neuroscience researchers have found that the auditory system adapts to the changing acoustics of reverberant environments by temporally shifting the inhibitory tuning of cortical neurons to remove reverberation.

Collaborative team driven by DPAG and Chemistry awarded RSC Horizon Prize

The Molecular Flow Sensor Team, with collaborating members principally from DPAG’s Robbins and Talbot groups and the Department of Chemistry, has been named the winner of the Royal Society of Chemistry’s (RSC) Analytical Division Horizon Prize for the development of a new technology for measuring lung function.

REF 2021 results

Oxford Parkinson’s Disease Centre awarded £3.8 million to reveal the role of calcium in Parkinson’s

A collaborative research team led by the Oxford Parkinson’s Disease Centre (OPDC) has been awarded a £3.8 million Wellcome Trust Collaborative Award to study the function of calcium in dopamine neurons, and how this is plays a role in Parkinson’s. Their research will help explain how and why dopamine neurons are vulnerable in the disease and look at how they may be preserved.